# A Study to Evaluate the Pharmacokinetics of Apatinib in Subjects With Impaired Renal Function

> **NCT04414852** · PHASE1 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Subjects With Impaired Renal Function and Healthy Subjects

## Interventions

- **DRUG:** Apatinib Mesylate

## Key facts

- **NCT ID:** NCT04414852
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-05
- **Primary completion:** 2021-01-15
- **Final completion:** 2021-04-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2020-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04414852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04414852, "A Study to Evaluate the Pharmacokinetics of Apatinib in Subjects With Impaired Renal Function". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04414852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*